IARC monographs on the evaluation of carcinogenic risks to humans

IARC Monographs on the Evaluation of Carcinogenic Risks to Humans

Volumn 93, Issue , 2010, Pages 9-38

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CARCINOGEN;

ARTICLE; BOOK; CANCER GENETICS; CANCER RESEARCH; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOGENICITY; CAUSAL ATTRIBUTION; CELL DAMAGE; CLINICAL EVALUATION; CONTENT ANALYSIS; ENVIRONMENTAL EXPOSURE; EVIDENCE BASED MEDICINE; EXPERIMENTAL ANIMAL; GENOTOXICITY; HEALTH HAZARD; HUMAN; MEDICAL INFORMATION; MOLECULAR GENETICS; NONHUMAN; OCCUPATIONAL EXPOSURE; PHYSICAL CHEMISTRY; PHYSIOLOGICAL PROCESS; PRIORITY JOURNAL; PROCESS DEVELOPMENT; PUBLICATION; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; SCIENTIFIC LITERATURE; SENSITIVITY AND SPECIFICITY; STUDY DESIGN; TOXICOKINETICS;

EID: 78449296061     PISSN: 10171606     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Article

References (40)

1. Bieler GS, Williams RL (1993). Ratio estimates, the delta method, and quantal response tests for increased carcinogenicity. Biometrics, 49:793-801 doi:10.2307/2532200.
2. Breslow NE, Day NE (1980). Statistical methods in cancer research. Volume I - The analysis of case-control studies. IARC Sci Publ, (32):5-338.
3. Breslow NE, Day NE (1987). Statistical methods in cancer research. Volume II-The design and analysis of cohort studies. IARC Sci Publ, (82):1-406.
4. Buffler P, Rice J, Baan R, editors (2004). Workshop on Mechanisms of Carcinogenesis: Contributions of Molecular Epidemiology. Lyon, 14-17 November 2001. Workshop report. IARC Sci Publ, (157):1-450.
5. Capen CC, Dybing E, Rice JM, Wilbourn JD (1999). Species Differences in Thyroid, Kidney and Urinary Bladder Carcinogenesis.Proceedings of a consensus conference. Lyon, France, 3-7 November 1997. IARC Sci Publ, (147):1-225.
6. Cogliano V, Baan R, Straif K et al. (2005). Transparency in IARC Monographs. Lancet Oncol, 6:747 doi:10.1016/S1470-2045(05)70380-6.
7. Cogliano VJ, Baan RA, Straif K et al. (2004). The science and practice of carcinogen identification and evaluation. Environ Health Perspect, 112:1269-1274.
8. Dunson DB, Chen Z, Harry J (2003). A Bayesian approach for joint modeling of cluster size and subunit-specific outcomes. Biometrics, 59:521-530 doi:10.1111/1541-0420.00062.
9. Fung KY, Krewski D, Smythe RT (1996). A comparison of tests for trend with historical controls in carcinogen bioassay. Can J Stat, 24:431-454 doi:10.2307/3315326.
10. Gart JJ, Krewski D, Lee PN et al. (1986). Statistical methods in cancer research. Volume III-The design and analysis of long-term animal experiments. IARC Sci Publ, (79):1-219.
11. Greenland S (1998). Meta-analysis. In: Rothman, K.J. & Greenland, S., eds, Modern Epidemiology, Philadelphia, Lippincott Williams & Wilkins, pp. 643-673
12. Greim H, Gelbke H-P, Reuter U et al. (2003). Evaluation of historical control data in carcinogenicity studies. Hum Exp Toxicol, 22:541-549 doi:10.1191/0960327103ht394oa.
13. Haseman JK, Huff J, Boorman GA (1984). Use of historical control data in carcinogenicity studies in rodents. Toxicol Pathol, 12:126-135 doi:10.1177/019262338401200203.
14. Hill AB (1965). The environment and disease: Association or causation? Proc R Soc Med, 58:295-300.
15. Hoel DG, Kaplan NL, Anderson MW (1983). Implication of nonlinear kinetics on risk estimation in carcinogenesis. Science, 219:1032-1037 doi:10.1126/science.6823565.
16. Huff JE, Eustis SL, Haseman JK (1989). Occurrence and relevance of chemically induced benign neoplasms in long-term carcinogenicity studies. Cancer Metastasis Rev, 8:1-22 doi:10.1007/BF00047055.
17. IARC (1977). IARC Monographs Programme on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Preamble (IARC intern. tech. Rep. No. 77/002)
18. IARC (1978). Chemicals with Sufficient Evidence of Carcinogenicity in Experimental Animals- IARC Monographs Volumes 1-17 (IARC intern. tech. Rep. No. 78/003)
19. IARC (1979). Criteria to Select Chemicals for IARC Monographs (IARC intern. tech. Rep. No. 79/003)
20. IARC (1982). Chemicals, Industrial Processes and Industries Associated with Cancer in Humans (IARC Monographs, Volumes 1 to 29). IARC Monogr Eval Carcinog Risk Chem Hum Suppl, 4:1-292.
21. IARC (1983). Approaches to Classifying Chemical Carcinogens According to Mechanism of Action (IARC intern. tech. Rep. No. 83/001)
22. IARC (1987). Overall evaluations of carcinogenicity: an updating of IARC Monographs volumes 1 to 42. IARC Monogr Eval Carcinog Risks Hum Suppl, 7:1-440.
23. IARC (1988). Report of an IARC Working Group to Review the Approaches and Processes Used to Evaluate the Carcinogenicity of Mixtures and Groups of Chemicals (IARC intern. tech. Rep. No. 88/002)
24. IARC (1991). A Consensus Report of an IARC Monographs Working Group on the Use of Mechanisms of Carcinogenesis in Risk Identification (IARC intern. tech. Rep. No. 91/002)
25. IARC (2004). Some drinking-water disinfectants and contaminants, including arsenic. IARC Monogr Eval Carcinog Risks Hum, 84:1-477.
26. IARC (2005). Report of the Advisory Group to Recommend Updates to the Preamble to the IARC Monographs (IARC Int. Rep. No. 05/001)
27. IARC (2006). Report of the Advisory Group to Review the Amended Preamble to the IARC Monographs (IARC Int. Rep. No. 06/001)
28. McGregor DB, Rice JM, Venitt S, editors (1999). The use of short-and medium-term tests for carcinogens and data on genetic effects in carcinogenic hazard evaluation. Consensus report. IARC Sci Publ, (146):1-536.
29. Montesano R, Bartsch H, Vainio H, editors (1986). Long-term and Short-term Assays for Carcinogenesis-A Critical Appraisal. IARC Sci Publ, (83):1-564
30. OECD (2002) Guidance Notes for Analysis and Evaluation of Chronic Toxicity and Carcinogenicity Studies (Series on Testing and Assessment No. 35), Paris, OEC
31. Peto R, Pike MC, Day NE et al. (1980). Guidelines for simple, sensitive significance tests for carcinogenic effects in long-term animal experiments. IARC Monogr Eval Carcinog Risk Chem Hum Suppl, 2 Suppl:311-426.
32. Portier CJ, Bailer AJ (1989). Testing for increased carcinogenicity using a survival-adjusted quantal response test. Fundam Appl Toxicol, 12:731-737 doi:10.1016/0272-0590(89)90004-3.
33. Sherman CD, Portier CJ, Kopp-Schneider A (1994). Multistage models of carcinogenesis: an approximation for the size and number distribution of late-stage clones. Risk Anal, 14:1039-1048 doi:10.1111/j.1539-6924.1994.tb00074.x.
34. Stewart BW, Kleihues P, editors (2003). World Cancer Report, Lyon, IARC
35. Tomatis L, Aitio A, Wilbourn J, Shuker L (1989). Human carcinogens so far identified. Jpn J Cancer Res, 80:795-807.
36. Toniolo P, Boffetta P, Shuker DEG, editors (1997). Proceedings of the Workshop on Application of Biomarkers to Cancer Epidemiology. Lyon, France, 20-23 February 1996. IARC Sci Publ, (142):1-318.
37. Vainio H, Magee P, McGregor D, McMichael A, editors (1992). Mechanisms of Carcinogenesis in Risk Identification. IARC Working Group Meeting. Lyon, 11-18 June 1991. IARC Sci Publ, (116):1-608.
38. Vainio H, Wilbourn JD, Sasco AJ et al. (1995). [Identification of human carcinogenic risks in IARC monographs]. Bull Cancer, 82:339-348.
39. Vineis P, Malats N, Lang M, editors (1999). Metabolic Polymorphisms and Susceptibility to Cancer. IARC Sci Publ, (148):1-510.
40. Wilbourn J, Haroun L, Heseltine E et al. (1986). Response of experimental animals to human carcinogens: an analysis based upon the IARC Monographs programme. Carcinogenesis, 7:1853-1863 doi:10.1093/carcin/7.11.1853.